ARMK.NYSEAramark

Form 4: Aramark CFO Exercises Options, Adjusts Holdings

Sentiment:

Insider Transaction Report


📋All filings for Aramark

Aramark's SVP and CFO, James J. Tarangelo, executed a net exercise of stock options, resulting in a change in his direct beneficial ownership of common stock.

Summary

  • James J. Tarangelo, SVP and CFO of Aramark, exercised 7,909 stock options on September 18, 2025, at an exercise price of $23.55 per share.
  • Concurrently, 6,199 shares of Common Stock were disposed of at a price of $37.645 per share to satisfy the exercise price and tax withholding obligations.
  • Following these transactions, Mr. Tarangelo's direct beneficial ownership of Aramark Common Stock stands at 50,164.846 shares.
  • The exercised stock options were fully vested and were set to expire on November 20, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (net exercise of stock options) which is neither inherently positive nor negative for the company's operational or financial performance. It reflects standard executive compensation practices.

Positives

  • The exercise of stock options indicates that the options were significantly in-the-money, with an exercise price of $23.55 compared to a disposition price of $37.645, reflecting value for the executive.
  • The transaction represents a routine monetization of executive compensation, which is a standard practice.

Negatives

  • The disposition of 6,199 shares, even for tax and exercise cost purposes, reduces the executive's direct equity stake in the company.

Future Outlook

This Form 4 filing is a transactional report and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide information relevant to broader industry trends or competitive analysis. It reflects an individual executive's compensation activity.

Stakeholder Impact

  • Shareholders: Minimal direct impact, as it's a routine executive compensation event. It may be viewed as a positive signal that options are in-the-money.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this transactional filing.

Key Dates

DateDescription
09/18/2025Date of option exercise and share disposition transactions.
09/19/2025Date the Form 4 was signed and filed.
11/20/2025Expiration date of the exercised stock options.

Keywords

Aramark, ARMK, Form 4, Insider Transaction, Stock Options, Executive Compensation, CFO, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.